The Glasgow Coma Scale is a neurological scale used to assess a person's level of consciousness after a traumatic brain injury or other acute medical conditions.
India has now developed a handheld device, Cerebo, to detect TBI, and it has received approval from the Drugs Controller General of India (DCGI).
Traumatic brain
injuries (TBIs) are a significant public health challenge, particularly in
emergency settings, rural areas, and underserved populations where advanced
diagnostic tools like CT or MRI scans are inaccessible or delayed.
India has now
developed a handheld device, Cerebo, to detect TBI, and it has received
approval from the Drugs Controller General of India (DCGI).
Developed through a collaboration between the
Indian Council of Medical Research- Medical Device and Diagnostics Mission
Secretariat, AIIMS Bhopal, NIMHANS Bengaluru, and Bioscan Research (ICMR-MDMS),
a handheld device called CEREBO has been developed to detect brain injuries.
“We use CT scans to detect brain injuries. This device is an easy alternative
to check for bleeding in the brain. It has received approval from DCGI,” ICMR
Director General Dr Rajiv Bahl said.
Globally, TBI
affects 69 million people, and more than 8 million are misdiagnosed. In its
annual report, ICMR has explained the efficiency of Cerebo over traditional
methods, such as the Glasgow Coma Scale and imaging techniques, which require
specialised infrastructure, trained personnel, and are cost-intensive.
The Glasgow Coma Scale is a neurological scale
used to assess a person's level of consciousness after a traumatic brain injury
or other acute medical conditions.
“To address this issue, Cerebo—a portable,
non-invasive brain injury diagnostic tool—has been developed using advanced
near-infrared spectroscopy technology powered by machine learning. Capable of
detecting intracranial bleeding and edema within a minute, Cerebo provides
color-coded, radiation-free, and cost-effective results. Designed for
deployment in ambulances, trauma centers, rural clinics, and disaster response
units, it enhances early TBI detection and patient outcomes,” ICMR said.
ICMR said that the device underwent clinical
validation, regulatory approvals, and feasibility studies, paving the way for
global adoption in emergency and military healthcare systems. Published in the
health journal Neurology India, the researchers mentioned that while Cerebo is
not intended to replace CT scans, it may be beneficial in instances where CT
scans are unavailable to study deep tissues non-invasively and bring
hospital-grade diagnosis to the point of care.
"This is especially relevant because nearly
half of patients with a head injury who get CT scans within 2 hours after
damage, especially those with cerebral contusions, are suspected to have early
progressive bleeding," said the study aimed at assessing the device.
No comments:
Post a Comment